JP2004518767A5 - - Google Patents

Download PDF

Info

Publication number
JP2004518767A5
JP2004518767A5 JP2002581413A JP2002581413A JP2004518767A5 JP 2004518767 A5 JP2004518767 A5 JP 2004518767A5 JP 2002581413 A JP2002581413 A JP 2002581413A JP 2002581413 A JP2002581413 A JP 2002581413A JP 2004518767 A5 JP2004518767 A5 JP 2004518767A5
Authority
JP
Japan
Prior art keywords
alkyl
het
aryl
cycloalkyl
alkanediyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002581413A
Other languages
English (en)
Japanese (ja)
Other versions
JP4530612B2 (ja
JP2004518767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/001788 external-priority patent/WO2002083657A2/en
Publication of JP2004518767A publication Critical patent/JP2004518767A/ja
Publication of JP2004518767A5 publication Critical patent/JP2004518767A5/ja
Application granted granted Critical
Publication of JP4530612B2 publication Critical patent/JP4530612B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002581413A 2001-02-14 2002-02-14 広域スペクトルの2−(置換−アミノ)−ベンゾチアゾールスルホンアミドhivプロテアーゼインヒビター Expired - Fee Related JP4530612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200529 2001-02-14
US28775801P 2001-05-02 2001-05-02
PCT/EP2002/001788 WO2002083657A2 (en) 2001-02-14 2002-02-14 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (3)

Publication Number Publication Date
JP2004518767A JP2004518767A (ja) 2004-06-24
JP2004518767A5 true JP2004518767A5 (https=) 2005-12-22
JP4530612B2 JP4530612B2 (ja) 2010-08-25

Family

ID=26076833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002581413A Expired - Fee Related JP4530612B2 (ja) 2001-02-14 2002-02-14 広域スペクトルの2−(置換−アミノ)−ベンゾチアゾールスルホンアミドhivプロテアーゼインヒビター

Country Status (30)

Country Link
US (1) US7659404B2 (https=)
EP (1) EP1370543B1 (https=)
JP (1) JP4530612B2 (https=)
KR (1) KR100870184B1 (https=)
CN (2) CN100369904C (https=)
AP (1) AP1504A (https=)
AT (1) ATE343567T1 (https=)
AU (1) AU2002302363B2 (https=)
BG (1) BG66301B1 (https=)
BR (1) BR0207862A (https=)
CA (1) CA2438304C (https=)
CY (1) CY1108073T1 (https=)
CZ (1) CZ304273B6 (https=)
DE (1) DE60215623T2 (https=)
DK (1) DK1370543T3 (https=)
EA (1) EA006096B1 (https=)
EE (1) EE05385B1 (https=)
ES (1) ES2275866T3 (https=)
HR (1) HRP20030735B1 (https=)
HU (1) HU229224B1 (https=)
IL (2) IL157171A0 (https=)
MX (1) MXPA03007236A (https=)
NO (1) NO326174B1 (https=)
NZ (1) NZ527391A (https=)
PL (1) PL213327B1 (https=)
PT (1) PT1370543E (https=)
SI (1) SI1370543T1 (https=)
SK (1) SK287582B6 (https=)
WO (1) WO2002083657A2 (https=)
ZA (1) ZA200306086B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246859T3 (es) 1999-05-28 2006-03-01 Virco Bvba Nuevos perfiles mutacionales en la transcriptasa inversa del vih-1 correlacionadas con una resistencia fenotipica a farmacos.
EP1356082A2 (en) 2000-10-20 2003-10-29 Virco Bvba Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
US7659404B2 (en) 2001-02-14 2010-02-09 Tibotec Pharmaceuticals Ltd. Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
AU2003202914A1 (en) 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
DE60321466D1 (de) 2002-07-01 2008-07-17 Tibotec Pharm Ltd Mit phänotypischer medikamentenresistenz korrelierte mutationsprofile in hiv-1-reverse-transkriptase
EP1520247B1 (en) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
CN1671380B (zh) * 2002-08-02 2010-05-26 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
OA12893A (en) * 2002-08-02 2006-10-13 Tibotec Pharm Ltd Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors.
BRPI0414916A (pt) * 2003-09-30 2006-11-07 Tibotec Pharm Ltd métodos para a preparação de compostos de sulfonamida de benzoxazol e intermediários dos mesmos
DE10360835A1 (de) * 2003-12-23 2005-07-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
US7378441B2 (en) * 2004-05-07 2008-05-27 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
DK1856125T3 (da) 2005-02-25 2009-12-07 Tibotec Pharm Ltd Syntese af proteasehæmmerforstadie
AR053845A1 (es) 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
JO3090B1 (ar) * 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
UY34750A (es) 2012-04-20 2013-11-29 Gilead Sciences Inc ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
CN116354903B (zh) * 2021-12-28 2025-09-09 南京药石科技股份有限公司 一种6-苯并噻唑磺酰氯的制备方法
WO2024206093A1 (en) * 2023-03-24 2024-10-03 Purdue Research Foundation Hiv-1p rotease inhibitors and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445926B1 (en) 1990-03-09 1996-08-21 Milliken Research Corporation Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
ES2123065T3 (es) * 1992-08-25 1999-01-01 Searle & Co Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
EP0715618B1 (en) 1993-08-24 1998-12-16 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
PT721331E (pt) 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
CA2210889C (en) 1995-01-20 2007-08-28 G.D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6140505A (en) * 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US6861539B1 (en) * 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
BR9607625A (pt) 1995-03-10 1999-06-15 Searle & Co Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
US6143788A (en) * 1995-03-10 2000-11-07 G.D. Searle & Co. Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
US5753660A (en) 1995-11-15 1998-05-19 G. D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1997044014A1 (en) 1996-05-20 1997-11-27 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
SK284813B6 (sk) 1997-03-26 2005-12-01 Janssen Pharmaceutica N. V. Peleta obsahujúca itrakonazol, spôsob jej prípravy a farmaceutická dávková forma s jej obsahom
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
EA200000702A1 (ru) * 1997-12-24 2000-12-25 Вертекс Фармасьютикалз Инкорпорейтед Пролекарства ингибиторов аспартилпротеаз
PT1086076E (pt) 1998-06-19 2005-05-31 Vertex Pharma Inibidores de sulfonamida de aspartil protease
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
CA2872424C (en) * 1998-06-23 2017-03-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv
AR031520A1 (es) * 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
US7659404B2 (en) 2001-02-14 2010-02-09 Tibotec Pharmaceuticals Ltd. Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors

Similar Documents

Publication Publication Date Title
JP2004518767A5 (https=)
CA2438304A1 (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
CN109476705B (zh) 新型环孢菌素衍生物及其用途
ES2393230T3 (es) Uso farmacéutico de amidas sustituidas
WO2018023054A1 (en) Protease transition state inhibitor prodrugs
EP4347034A1 (en) Protease inhibitors as antivirals
RU2601742C2 (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
AR036046A1 (es) Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos
RU2004109815A (ru) Пирролопиримидины в качестве средств ингибирования цистеинпротеаз
PL187747B1 (pl) Zastosowanie sulfonamidowego inhibitora proteazy HIV
EP2585054A1 (en) Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
JP2008526999A5 (https=)
WO2010002994A1 (en) Nonpeptide hiv-1 protease inhibitors
JP6454335B2 (ja) カテプシンシステインプロテアーゼ阻害剤
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
JP2008519824A5 (https=)
ES2341778T3 (es) Aplicacion topica de tiazolilamidas.
CA2442870A1 (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
HU201337B (en) Process for producing dipeptide-glycerides and pharmaceutical compositions containing them
US9309213B2 (en) C-3 substituted bicyclooctane based HIV protease inhibitors
US20130274254A1 (en) Inhibitors of cytochrome p450 (cyp3a4)
ES2689654T3 (es) Preparación de productos intermedios de cobicistat
US12583820B2 (en) Broad spectrum antivirals against coronavirus
CN114667281B (zh) 具有抗hiv活性的cd4模拟物化合物
US7915237B2 (en) Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate and medicaments therefrom